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Abstract
Previously, a candidate gene linkage approach on brother pairs affected with prostate cancer identified a locus of prostate
cancer susceptibility at D3S1234 within the fragile histidine triad gene (FHIT), a tumor suppressor that induces apoptosis.
Subsequent association tests on 16 SNPs spanning approximately 381 kb surrounding D3S1234 in Americans of European
descent revealed significant evidence of association for a single SNP within intron 5 of FHIT. In the current study, re-
sequencing and genotyping within a 28.5 kb region surrounding this SNP further delineated the association with prostate
cancer risk to a 15 kb region. Multiple SNPs in sequences under evolutionary constraint within intron 5 of FHIT defined
several related haplotypes with an increased risk of prostate cancer in European-Americans. Strong associations were
detected for a risk haplotype defined by SNPs 138543, 142413, and 152494 in all cases (Pearson’s x2 = 12.34, df 1,
P= 0.00045) and for the homozygous risk haplotype defined by SNPs 144716, 142413, and 148444 in cases that shared 2
alleles identical by descent with their affected brothers (Pearson’s x2 = 11.50, df 1, P= 0.00070). In addition to highly
conserved sequences encompassing SNPs 148444 and 152413, population studies revealed strong signatures of natural
selection for a 1 kb window covering the SNP 144716 in two human populations, the European American (p= 0.0072,
Tajima’s D= 3.31, 14 SNPs) and the Japanese (p= 0.0049, Fay & Wu’s H= 8.05, 14 SNPs), as well as in chimpanzees (Fay &
Wu’s H= 8.62, 12 SNPs). These results strongly support the involvement of the FHIT intronic region in an increased risk of
prostate cancer.
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Introduction
The genetic complexity of prostate cancer has been well-
demonstrated by independent, large-scale, genome-wide association
studies that identified multiple risk loci throughout the human
genome [1,2,3,4,5,6]. These loci each only moderately increases a
person’s risk of the disease by up to 60% and may collectively
account for over 50% of the genetic risk of prostate cancer observed
in the human population. Additional risk loci remain to be
discovered through meta-analysis of existing data and further study.
We recently used linkage analysis of candidate genes and
subsequent association tests to implicate a 30 kb region within
intron 5 of FHIT in prostate cancer risk [7]. The FHIT gene, which
encodes a 16.8 kD triphosphatase, comprises 10 short exons
spanning approximately 1.5 Mb. It resides at the most frequently
observed fragile site in the human genome, FRA3B (3p14.2); and it is
one of the earliest and most frequently deleted regions in multiple
cancer types [8,9]. Although deletion of the FHIT gene in prostate
cancer tissue has not been widely reported, loss of heterozygosity
(LOH) has been reported in 2 of 15 tumors through the use of
microsatellite markers located in introns of FHIT [10]. Loss of FHIT
was also detected in an in vitro model of a prostate cancer tumor cell
line that was established by using HPV-18 to immortalize a normal
adult human prostate epithelium cell line, followed by malignant
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transformation through exposure to a chemical carcinogen [11,12].
Immunohistochemical analysis in primary cancer tissue confirmed
the absence or greatly reduced expression of FHIT protein levels in
tumor cells, in contrast to high levels of expression in the adjacent
normal prostate epithelium [12,13].
Although FHIT protein expression is lost or reduced in many
types of human cancers [9], the mechanistic basis for the
involvement of intron 5 in genetic risk of prostate cancer is not
apparent. A germ-line alteration in FHIT that is associated with
cancer risk has not been reported, possibly because of limitations of
previous studies that focused only on exons, untranslated regions of
mRNA, and promoters. Characteristic landmarks of a fragile region,
such as aphidicolin-induced hybrid breaks, HPV16 integration sites,
pSV2neo integration sites, and deletion end points in cancer cell
lines, have been identified within introns of FHIT [14]; however,
these landmarks do not overlap with the region within intron 5 that
we implicated in prostate cancer risk. FHIT plays an important role
in inducing apoptosis of cells responding to DNA damages caused by
exposure to a variety of environmental agents, such as radiation,
viruses, and toxic chemicals present in tobacco smoke and tin mines
[15,16,17]; yet the genetic elements that control such processes have
not been identified.
The evolutionary forces of mutation, natural selection, genetic
drift, and recombination have shaped the pattern of variation in the
human genome. Natural selection, which acts on functionally
important genetic variations that result in alteration of fitness, such as
adaptation to local environment and disease susceptibility, may leave
specific signatures on affected loci [18], and analysis of genetic
variation in populations is becoming central to understanding the
function of genes [19,20]. Screening for signatures of natural
selection may help uncover novel functional elements. Therefore, we
used this approach to determine whether evidence of selection could
be detected within the 30 kb FHIT intronic region. We conducted a
re-sequencing survey and analyzed linkage disequilibrium (LD) and
haplotype structure in sequences from intron 5 of FHIT in European
American, Yoruban, and Japanese populations, and several non-
human primates. Based on these data, we refined the region
associated with prostate cancer risk to a 15 Kb LD block and
revealed strong signatures of selection in multiple human popula-
tions and, possibly, other primate species.
Results
Re-sequencing
Larson et al. [7] tested 16 SNPs spanning a 381 kb region
within intron 5 of FHIT for association with prostate cancer risk
and detected a significant association with one of the SNPs,
rs760317. A less significant association with prostate cancer risk
was found at a closely linked SNP, rs722070, located 13 kb from
rs760317 on the centromeric side; no association was detected
with SNPs on the telomeric side. To map the association with
prostate cancer risk at high resolution and look for evidence of
selection, we conducted a re-sequencing survey using 13 randomly
chosen cases and controls of European-American descent. The
total surveyed sequence length was 28.5 kb, excluding two un-
amplifiable sequence gaps of 487 bp and 263 bp. One of the gaps
contained an AT repeat and a long poly A tract, and the other
contained AT and AG repeats. Two fragments of this region with
lengths of 19 kb (from 134 kb to 153 kb; GeneBank Accession
#AF152364) and 7 kb (from 142 kb to 149 kb internal to the
19 kb; GeneBank Accession #AF152364) were also sequenced in
16 Yoruban and 16 Japanese individuals, respectively.
Across the entire region, we identified 216 SNPs and 9 indels,
ranging from 1 to 24 bp, in the 13 European-American individuals
(Table S1). Within the 19 kb region, sequenced in both European-
Americans and Yorubans, we found 146 SNPs and 7 indels common
to both populations, 99 SNPs and 1 indel unique to Yorubans, and
19 SNPs and 1 indel unique to European Americans. Within the
7 kb region sequenced in all three populations, we detected 64 SNPs
and 4 indels common to the three populations; 28 SNPs and 1 indel
unique to Yorubans; 2 SNPs unique to European-Americans; 1 SNP
unique to the Japanese; and 9 SNPs and 1 indel common to two
populations. Indels and SNPs within long tracks of simple repeats
were not included in these statistics and subsequent analyses because
of the low accuracy of sequencing in these areas.
Linkage disequilibrium (LD)
We calculated pair-wise r2 based on SNPs with a minor allele
frequency greater than 0.05 (196 SNPs for the 13 European-
Americans samples and 178 SNPs for the 16 Yorubans samples)
using Haploview (Fig. 1A and C) and recombination rates with
hotspots using rhomap (Fig. 1B). Consistent with previous reports
[21,22], we observed much less LD in the African sample, although
the pattern of LD was otherwise similar between the populations.
The most noticeable difference between the two populations was a
15 kb LD block in the European American population which was
disrupted by much higher background recombination rate and at
least one recombination hotspot in the Yoruban population (Fig. 1B).
We selected 48 SNPs from the re-sequencing survey and three SNPs
published in Larson et al. [7] that represented the basic LD structure
and genotyped these SNPs in all case and control samples to evaluate
their association with prostate cancer.
Association Tests
We performed association tests on individual SNPs and
haplotypes of SNP combinations. Since the original linkage data
predicted a recessive model [7], we hypothesized that the
subgroup of cases that shared 2 alleles identical by descent (IBD)
at this locus with their brothers (2 IBD cases) would be the major
contributors to the observed genetic signal. Therefore, we
compared SNP frequencies in controls against all cases and 2
IBD cases (Table S2). Significant association (cutoff P=0.05, not
corrected for multiple testing) was observed for several SNPs and
maximized at 137302 (rs9814915, Pearson’s x2 = 5.16, degrees of
freedom (df) 1, P=0.0231) for all cases (single open circles in
Fig. 2A) and 138543 (rs760317, Pearson’s x2 = 7.42, df 1,
P=0.0064) for the 2 IBD subgroup (single black circles in Fig. 2A).
Screening for haplotype association for all three-SNP combina-
tions revealed that the strongest association of prostate cancer risk
was with a haplotype defined by SNPs 135181, 142413, and 152494
in 2 IBD cases (haplotype G-G-T was enriched in 2 IBD cases,
x2= 9.73, df 1, P=0.0018, Table S3) and SNPs 138543, 142413,
and 152494 in all cases (haplotype A-G-T was enriched in all cases,
x2= 13.72, df 1, P=0.00021, Table S3). Adding any other single
SNP to the combination did not increase the association with prostate
cancer risk, while omitting any SNP in the combinations significantly
reduced the signal (data not shown). Consistent with a recessive
model, samples that were homozygous for the risk haplotype were
significantly enriched in cases as compared to controls.
Interestingly, both SNP combinations identified in all cases and 2
IBD cases included SNPs 142413 and 152494, which individually
exhibited very limited association with prostate cancer risk. SNP
152494 was located within a highly conserved non-coding sequence,
and SNP 142413 was located within 100 bp of another highly
conserved non-coding sequence (Fig. 2A). Neither SNP was in strong
LD with any other SNP genotyped in cases and controls. However,
SNP 135181 was in strong LD with SNP 138543 (r2 = 0.86) and
several other genotyped SNPs, 135240, 137261, 139813, 144716,
FHIT Intron in Cancer Risk
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147904 (r2 ranging from 0.87 to 0.97, highlighted SNPs in Fig. 2A).
Therefore, these other SNPs also exhibited a compelling association
to prostate cancer risk in combination with SNPs 142413 and
152494 (SNP combinations represented by open circles linked with a
line in Fig. 2A and Table S3). An additional 21 SNPs were known to
be strongly linked to 135181 based on sequencing data. Among all
the SNPs linked to 135181, only 147907 was located within a highly
conserved sequence (Fig. 2A). Therefore, SNP 147907 may be a
likely candidate for causality.
A SNP, 148444, located within a highly conserved sequence,
showed the highest LD (r2= 0.37) with SNP 152494 among all
genotyped SNPs. Replacing SNP 152494 with 148444 in the three-
SNP combinations also defined a haplotype for which homozygotes
were especially enriched in cases (Table S3). Consistent with a
recessive model, we found the strongest association with homozy-
gotes of the risk haplotype in 2 IBD cases (SNP combinations
represented by black circles linked by a line in Fig. 2A)—even
stronger than most combinations with SNP 152494.
SNPs Underscoring a Signature of Natural Selection in
Humans Are Associated with Prostate Cancer Risk
To discriminate SNPs that might contribute functionality
among the SNPs showing strong association with prostate cancer
risk, we used re-sequencing data from European-American,
Figure 1. Local linkage disequilibrium (LD) structure and recombination rates (based on SNPs with minor allele frequencies
.=0.05 in a 30 kb region of FHIT intron 5). A. Graphical representation of pair-wise r2 (from 0 to 1 represented with gray scale from white to
black) calculated and visualized using Haploview for 13 European Americans. B. Recombination rates (Rho) calculated using rhomap for Yorubans (red
line, with SNP positions represented by open circles) and European Americans (black line, with SNP positions denoted by solid diamonds) based on
sequencing data. The grey line with solid triangles was based on genotyping data on 51 SNPs from 25 cases and 25 controls (European Americans). C.
Graphical representation of r2 using for 16 Yorubans. A solid black bar represented a 15 kb LD block in the European American.
doi:10.1371/journal.pone.0003533.g001
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Yoruban, and Japanese populations to search for signatures of
natural selection, in addition to conservation, within the 28.5 kb
region. Several key statistics were calculated using SLIDER. We
compared these population parameters in the FHIT interval to
those obtained in the HapMap ENCODE Sequencing Project, in
which 10 regions of 500 kb from various chromosomes in four
human populations were sequenced in their entirety. These
ENCODE data provided a reasonable control for the genome-
wide distribution of population-specific statistics. To confirm the
statistics observed in the 13 randomly-selected cases and controls,
we also sequenced a 2 kb region containing the maximum
Tajima’s D value in 14 CEPH individuals. Because the
ENCODE data do not provide genotypes on indels, we also
excluded indels from our FHIT region in population analyses
and comparisons.
We observed a striking increase of nucleotide diversity that
spanned multiple LD blocks for the three human populations
(Fig. 2B). The maximum p was 0.0072 (0.0065 for the 14 CEPH
individuals), 0.0077, and 0.0049 for European-American, Yoru-
ban, and Japanese populations, respectively, compared to an
average of 0.00071 (0.000071 to 0.0055), 0.00074 (0.00013 to
0.0046), and 0.00076 (0.00013 to 0.0050) within the 5 Mb
ENCODE regions. Therefore, the maximum p observed within
the 28.5 kb region in intron 5 of FHIT exceeded the maximum p
observed from the 10 ENCODE regions for both European-
Americans and Yorubans (p,0.0060 for both populations).
We also detected a significant increase of Tajima’s D in the
European-American population (Fig. 2C). The 1 kb window of
maximum Tajima’s D (3.31, P=0.003 assuming standard neutral
model I; P=0.006 assuming neutral model II; P=0.021 assuming
Figure 2. Co-localization of SNP association and natural selection. A. Association tests of single SNPs and haplotypes. Individual SNPs were
anchored on an UCSC Genome map with Multiz alignment and conservation of vertebrates (v166; http://genome.ucsc.edu) for the 30 kb region. The
region was represented with an open bar in an inset at the upper left corner depicting single SNP tests surrounding a broader 381 kb region. An
arrow pointed to the microsatellite marker, D3S1234, exhibiting the strongest linkage signal in the original study. A solid black bar corresponds to the
15 kb LD block in the European American. Tests on allele frequency for individual SNPs are denoted by circles (open for all cases and black for 2 IBD
cases). Tests for risk haplotyes are represented by circles linked with lines. SNPs highlighted in red are in strong LD (r2.0.9) with each other. B.
Nucleotide diversity (p) calculated for Yorubans (red line), European Americans (black line), and Japanese (blue line). C. Tajima’s D calculated for
Yorubans (red line), European Americans (black line), and Japanese (blue) using SLIDER. D. Diversity between human and chimpanzee sequences
(dark green line including SNPs in humans and light green line excluding SNPs in humans).
doi:10.1371/journal.pone.0003533.g002
FHIT Intron in Cancer Risk
PLoS ONE | www.plosone.org 4 October 2008 | Volume 3 | Issue 10 | e3533
neutral model III) corresponded to the window of maximum p. In
the 14 CEPH individuals, the same window exhibited a Tajima’s
D of 3.11. Only one small ENCODE region, less than 0.6% of all
ENCODE regions, displayed a higher maximum Tajima’s D. A
significant Fay & Wu’s H value (8.05 for 14 SNPs, P=0.0067,
assuming a standard neutral model I) was detected for the same
window in the Japanese population. A 14-SNP sliding window
analysis for all ENCODE regions in the Japanese population
found 237 of 6265 windows with a Fay & Wu’s H value greater
than 8.05 (P=0.038).
To determine if the greater nucleotide diversity was due to an
increase in the local mutation rate, we evaluated the nucleotide
differences in the 28.5 kb sequenced region by comparing one
human sequence with one chimpanzee sequence retrieved from
the UCSC genome browser. For each 1 kb window across the
28.5 kb region, the divergence between the human and the
chimpanzee sequences ranged from 0.004 to 0.026 and averaged
0.0145 (Fig. 2D). For the 1 kb region with the maximum p in the
European-American population, we observed a divergence of
0.0150. Divergence values for the adjoining 5 and 10 kb were
0.0137 and 0.0149, respectively. These statistics were only slightly
higher than the average for the chimpanzee genome (0.0123 [23]).
When SNPs that are observed in human populations were
excluded, the divergence was significantly reduced (ranging from
0.002 to 0.022 and averaging 0.0112), especially within the region
that showed high nucleotide diversity in humans (Fig. 2D). These
observations excluded a higher local mutation rate as a major
cause of greater diversity in human populations.
Two SNPs, 144716 and 144552, within the 1 kb window that
showed the maximum signal of natural selection, were in strong
LD with 135181 and demonstrated a comparable level of
association to prostate cancer risk in combination with SNPs
142413 and either 152494 or 148444 (Table S3). The region from
142 kb to 149 kb displayed significantly higher nucleotide
diversity among European-Americans than Yorubans, in contrast
to surrounding regions and the vast majority of the human
genome, in which Yoruban diversity is generally similar to or
higher than European-American diversity (Fig. 2B). This region
also encompassed three SNP combinations: 142413, 144716 or
147904, and 148444, each residing within a sequence under
natural selection and jointly delineating the putative risk
haplotype. This overlap of selection and significant association
signals implicated co-evolution and interactive functions among
the sequence modules in their involvement in prostate cancer risk.
Signatures of Selection in Non-Human Primates
Sequencing data in the same 1 kb window in common western
chimpanzees and bonobos also revealed potential natural
selection. Although the chimpanzee sequence possessed a
completely different collection of SNPs compared to the human
sequence, the haplotype distributions exhibited a pattern similar to
that of the Japanese population: predominantly one haplotype
with extremely high frequencies of the derived allele for multiple
SNPs (Tajima’s D=21.81, Fu and Li’s D=23.02, p=0.0015). A
significantly high Fay & Wu’s H (8.62 for 12 SNPs, P=0.0001
assuming the standard neutral model) suggested a hitchhiking
effect under a recent positive selection. For the bonobo sequence,
two rare SNPs, each observed only once in the 6 individuals, and
no fixed nucleotide change were present in the 1 kb window
(Tajima’s D=21.45, FuLi D=21.72, p=0.00034) compared to
chimpanzee sequence.
Three subspecies are recognized among common chimpanzees
based on their geographic distribution: Pan troglodytes verus (Ptv) in
western Africa, Pan troglodytes troglodytes (Ptt) in central Africa, and
Pan troglodytes schweinfurthii (Pts) in eastern Africa. Previous studies
suggested distinct demographic histories for the three subspecies,
resulting in a slightly positive average value of Tajima’s D for
western chimpanzees (Ptv) and a significantly negative average
value of Tajima’s D for central chimpanzees (Ptt). To establish a
genome-wide distribution of population statistics for the common
chimpanzees, we retrieved and reanalyzed sequence data from two
previous studies: 50 intergenic regions (Genebank acc.#
AY276396 to AY277244) sequenced in 17 common chimps (6
Ptv, 5 Ptt, 2 Pts, and 4 unknown) [24] and 10 non-coding regions
sequenced in 14 central chimpanzees [25] from the NCBI
database (Table 1). The statistics observed in the 1 kb target
region (Tajima’s D=21.81, Fu & Li’s D=23.02) placed it
among the lowest of genome-wide distributions. Sequencing data
for a larger number of primate individuals that is analyzed
separately for each subspecies will be required to evaluate the
effect of natural selection with higher confidence. Nevertheless,
these preliminary data are consistent with signatures of selection in
a primate species other than humans.
Discussion
Previous linkage and association studies identified an approx-
imately 30 kb region associated with prostate cancer risk. In this
report, detailed analysis of local LD structure and additional
association tests refined the maximum signal to within a 15 kb
region, possibly involving a haplotype defined by three or more
SNPs within sequences under strong evolutionary constraint.
Evidence of both association and selection supported important
and interactive functions for sequences within the 15 kb intronic
region of FHIT. The risk haplotypes defined by major alleles of
several SNPs in combinations were not in complete LD with any
single SNP discovered in the 28.5 kb region and exhibited much
stronger associations with prostate cancer than any single SNP
tested. Among the 9 SNPs that delineated risk haplotypes, four
(142413, 147904, 148444, and 152494) were located within or
Table 1. Summary statistics of common chimpanzees based on previously published sequencing data.
Subspecies Name
(# of Individual)
# of Regions (# of
Chromosome)
Total Sequenced
Length (kb) Tajima’s D Fu & Li’s D Reference
Average Max. Min. Average Max. Min.
Ptv. (6) 50 (17) 23 0.093 1.67 21.63 0.17 1.26 21.95 [24]
Ptt. (5) 50 (17) 23 20.42 1.30 21.90 20.41 1.15 22.22
Combined (17) 50 (17) 23 20.99 1.00 22.01 21.07 1.27 23.61
Ptt (14) 9 (8) 19 20.95 0.85 22.12 20.36 1.44 22.60 [25]
doi:10.1371/journal.pone.0003533.t001
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near sequences that are highly conserved among mammals; and
one (144716) was located within a sequence that exhibited
significant and distinct signals of natural selection within diverse
human and primate populations. The alleles of 5 SNPs (142413,
135181, 137261, 138543, and 144716) in risk haplotypes were
ancestral. The alleles of both SNPs 148444 and 152494 in risk
haplotypes were derived and reached very high frequency (.0.8)
in all three human populations tested; therefore, they appeared to
be under positive selection, especially in the Yoruban population.
For example, SNP 148444 overlapped with 1-kb windows of
minimum Tajima’s D (21.804 for 10 SNPs) and elevated Fay and
Wu’s H (9.31 for 17 SNPs) in the Yoruban population.
Levin et al. [26] recently reported an inverse association of
prostate cancer risk to the SNP, rs760317 (138543), described in
our original study [7]. The authors attributed the association of the
‘‘flipped’’ allele (G instead of A) to (i) a high minor allele frequency
of rs760317, (ii) an unidentified additional causal SNP of relatively
low linkage disequilibrium with rs760317, and (iii) no consider-
ation of the interaction between the two in their analysis model. In
the current study, we identified two additional SNPs, 142413 and
152494 or 148444, that interact with either SNP 138543 or a SNP
in very high LD with 138543, such as 144716, that determined the
risk of prostate cancer. Pairwise LD measurements among the
three interacting SNPs were indeed very low (r2,0.3 for all
possible pairs), consistent with the hypothesis originally proposed
by Lin et al. [27] to explain a flipped association.
Detection of signatures of natural selection has been proposed to
map genes and regulatory elements involved in human diseases
[18,28]. In this paper, we used evidence of natural selection to infer
functionality of an intronic region implicated in prostate cancer [7].
Since we detected strong signals of both positive and balancing
selection within the same region for different human and non-
human primate populations, chance and demographic history alone
can not fully explain our observations. To control for the effect of
demographic history, we confirmed high Tajima’s D and p in the
same individuals which have been sequenced in the ENCODE
Sequencing Project and provided a genome-wide background.
Therefore, natural selection presents a plausible explanation for the
non-random distribution of SNP genotypes existing in the data.
Population genetics in this region suggested that diverse
selective forces may have been acting on different populations of
humans and primates. It is, therefore, intriguing that the FHIT
gene is known for its responsiveness to environmental factors, such
as smoking [15] and radiation exposure [17], and mediates cell
survival or apoptosis [9]. We compared synonymous and
nonsynonymous changes in the FHIT coding region between the
human and the chimpanzee and found 4 synonymous and 2
nonsynonymous changes within its 441 bp coding region. Both
nonsynonymous changes altered the chemical properties of amino
acids involved, implying that FHIT might be one of the fast-
evolving genes subjected to positive selection.
Conventional association studies have largely focused on known
coding sequences, which account for only approximately 1.5% of
the human genome. However, recent studies have revealed large
populations of previously unknown RNA transcripts, most of
which are non-coding, within introns and intergenic regions
[29,30]. Many of these transcripts are involved in tumorigenesis
[31] including prostate tumor differentiation [32]. Multiple
independent studies have also confirmed the role of non-coding
regions on 8q24 in susceptibility to prostate cancer [2,33]. Within
the region we implcated in prostate cancer risk, a genome-wide
effort to predict conservation of RNA secondary structure using
the computer program, EvoFold [34], detected a 61-bp conserved
structure surrounding the SNP 148444. Whether such elements
within intron 5 locus convey prostate cancer risk through
alteration of FHIT expression/function or through unrelated
intronic functional elements remains to be investigated.
Materials and Methods
Study Subjects
The case and control samples have been described previously [7].
The study and the use of the tissues have been approved by
institutional review board at each participating site. Informed written
consent was obtained from all participants. Briefly, DNAs from 200
unrelated patients of European descent affected with prostate cancer
and 143 controls of matched ethnicity were used in the current study.
Informed consent was obtained from all participants. In addition,
DNA from 14 CEPH (European American), 16 Yoruban (African),
and 16 Japanese individuals was obtained from the Coriell Cell
Repositories. Samples from the 14 CEPH individuals, 8 of the
Yorubans, and 8 of the Japanese had been re-sequenced in the
HapMap ENCODE Resequencing Project.
We obtained the primate DNA panel (PRP00003) from the
Coriell Cell Repositories. The sample included one individual
from each of the following species: common chimpanzee, bonobo,
gorilla, Sumatran orangutan, pigtailed macaque, rhesus monkey,
black-handed spider monkey, common woolly monkey, red-
chested mustached tamarin, and ring-tailed lemur. We also
obtained DNA of another 12 unrelated common western
chimpanzees (NS03622, NS03623, NS03639, NS03641,
NS03650M NS03656, NS03660, NA03450, NG06939,
NS03489, NS03610, and NS03659; personal communication,
W. Winckler, The Broad Institute, Cambridge, MA) from the
Coriell Cell Repository, as well as DNA from five additional
unrelated bonobo individuals (identifiers available on request).
SNP genotyping
Genomic DNA was extracted as described previously [7]. SNP
genotypes were obtained and critical SNPs were confirmed using a
combination of ABI SNaPshotTM genotyping on an ABI377 DNA
sequencer, Sequenom iPLEX SNP typing on a MassARRAY
system, and sequencing on ABI3130xl and ABI 3730 platforms.
Re-sequencing
Genomic DNA was amplified using overlapping PCR primers
and re-sequenced using PCR and internal primers. SNPs were
detected using PolyPhred 4.0 [35] and Consed [36]. To minimize
the false negative rate, we used a low -score setting of 50 to tag all
possible SNPs and inspected each SNP manually to verify the
accuracy of sequence assignments. Indels were recorded through
manual inspection.
Statistical Analyses
We used Haploview [37] to perform x2 tests of Hardy-Weinberg
equilibrium (HWE) for each marker genotyped in cases and controls
and found no extreme deviation. We also used Haploview to
calculate and visualize r2 between each pair of markers (minor allele
frequency, MAF, $5%), and to compare allele frequencies of cases
and controls. Recombination rates were calculated using rhomap
[38] with 10000000 runs and 1000000 burn-ins. Screening for
individual haplotype association of 3 SNP combinations was
achieved using UNPHASED [39]. Significant SNP combinations
were verified using an online Pearson’s chi-square test [40] andOdds
Ratio test [41] on haplotype (inferred by PHASE 2.1 [42,43])
frequencies and genotype frequencies comparing risk haplotype
against all other combined, and a permutation test for ‘‘Haplotypes
in Blocks Only’’ implemented in Haploview.
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We used an online program, SLIDER (http://genapps.uchicago.
edu/slider/index.html), to obtain several population statistics,
including the average pair-wise difference, p [44], summaries of
allele frequencies, Tajima’s D [45], Fu and Li’s D [46], and Fay and
Wu’s H [47]. A window of 1000 bp and increment of 100 bp were
applied for all analyses unless otherwise indicated.
Model Simulations
We tested the significance of observing a given statistic by
simulating sample sets under neutral models using MS, as described
by Hudson [48]. The genome average of positive Tajima’s D values
reported for non-African populations suggests that models that
include population structure and reduction in population size may be
compatible with data displaying large positive deflections of D (see
Results) [49]. Therefore, we considered three neutral models: a
standard neutral model (neutral model I, average Tajima’s
D=20.08); a neutral model assuming a population structure of
four subpopulations of equal size with migration parameter,
4N0m=0.7 (neutral model II, average Tajima’s D=0.4); and a
neutral model assuming a recent bottleneck, in which a population
was reduced to 0.35 of its original size at T2=0.0375 in units of 4N0
generations, followed by a population expansion starting at
T1=0.000375 and reaching its current size of 1.5 times its original
size (neutral model III, average Tajima’s D=0.4). Sample sets were
always simulated with the same fixed number of segregating sites as
observed in the region being simulated. A Bonferroni correction was
applied whenever multiple windows were considered.
Sample sets of natural selection models were simulated using
SelSim [50], with a fixed number of segregating sites as the DNA
segment of interest. Population statistics were calculated using
SLIDER as described above.
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